Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-55695
J Reprod Dev 2019 Jun 14;653:203-208. doi: 10.1262/jrd.2019-002.
Show Gene links Show Anatomy links

Various nuclear reprogramming systems using egg and oocyte materials.



???displayArticle.abstract???
Maternal factors stored in eggs and oocytes are necessary for reprogramming sperm for embryonic development. This reprogramming activity of maternal factors also works towards somatic cells, including terminally differentiated cells. Several different experimental systems utilizing egg and oocyte materials have been applied to study nuclear reprogramming by maternal factors. Among these systems, the most widely used is the transfer of a somatic cell nucleus to an oocyte arrested at the metaphase II stage, leading to the production of a cloned animal. Nuclear transfer to an unfertilized oocyte thus provides a unique opportunity to examine reprogramming processes involved in acquiring totipotency. Other experimental systems are also available to study maternal reprogramming, such as nuclear transfer to Xenopus laevis oocytes at the germinal vesicle stage, treatment with extracts obtained from eggs or oocytes, and induced pluripotency with overexpressed maternal factors. Each system can be used for answering different types of scientific questions. This review describes currently available reprogramming systems using egg and oocyte materials and discusses how we can deepen our understanding of reprogramming mechanisms by taking advantage of these various experimental systems.

???displayArticle.pubmedLink??? 30745498
???displayArticle.pmcLink??? PMC6584177
???displayArticle.link??? J Reprod Dev




???attribute.lit??? ???displayArticles.show???
References [+] :
Allegrucci, Epigenetic reprogramming of breast cancer cells with oocyte extracts. 2011, Pubmed, Xenbase